Our goal was to investigate whether previously related antiapoptotic and anti-inflammatory effects of tacrolimus could be useful in protecting human islets cultured in the presence of several proinflammatory mediators. Human islets obtained from cadaveric donors after intraductal infusion with collagenase, mechanical digestion, and continuous Ficoll gradient purification were cultured in RPMI-1640 medium for 24 h. Escherichia coli lipopolysaccharide (10 µg/ml) or interleukin-1 (50 UI/ml) + γ-IF (1000 UI/ml) and low-dose tacroliumus (5 ng/ml) were added. Homogenized samples (300 IE) from five different donors where assigned to four different experimental groups (control, treatment, cytokines, and cytokines + treatment). To evaluate islet damage and apoptotic response, nucleosome content, Bcl-2 protein levels, caspase-3, -8, and -9 levels, and insulin concentration were measured. Also, TNF-α and IL-6 levels where assessed as indicators of the inflammatory response. All proapoptotic markers, TNF-α, and IL-6 levels were augmented after both LPS and cytokine stimulation. Tacrolimus reduced significantly all of them and restored baseline values of nucleosome and caspase-9 in both experiments and Bcl-2 and caspase-3 when IL-1 + γ-IF was added. Twenty-four-hour insulin concentration diminished when LPS or IL-1 + γ-IF were present. Tacrolimus treatment restored insulin levels in both experiments. These results suggest that in vitro apoptotic events and media insulin concentration decrease after proinflammatory stimulation can be reverted using low-dose tacrolimus.
INTRODUCTION
contained in collagenase blends and host local immune response have also been pointed as important triggers for primary nonfunction mechanisms (41). Pancreatic islet transplantation is an effective alternative for type 1 diabetes mellitus patients. Recent ad-Also, it has been shown that there is a proinflammatory cytokine release from intraislet macrophages, ductal vances in donor and recipient selection, isolation procedure, and immunosuppressive protocols have helped and vascular cells, and even β-cells during nonspecific immune response, which activates apoptosis of the islet significantly to achieve better clinical results in terms of insulin independence and metabolic control (32, 34) . cells (3, 15) . Mechanical, chemical, and ischemic stress generated since pancreas procurement and isolation pro-Along with donor shortage and persistent autoimmunity, allograft rejection remains as the most important prob-cedures also contribute to apoptosis of the implanted islets cells (3) . Not surprisingly, both unspecific inflam-lem to solve (31) . However, the limited islet graft survival is due to, among others, several factors that gener-matory response amelioration and apoptosis blockade have shown promising results improving islet viability, ate a nonspecific inflammatory response. In addition, innate immunity seems to be involved and cause an im-function, and graft survival (2, 24) . Common immunosuppressive protocols used in clini-portant islet mass loss and graft failure within the first 24-48 h after transplantation (26) . In fact, early primary cal islet transplantation include low-dose tacrolimus (32) . Despite the fact this calcineurin inhibitor has been nonfunction occurs also in autologus and syngeneic transplantation without T-cell infiltration (6) and is cor-related to long-term diabetogenic side effects and β-cell regeneration impairment (2), both antiapoptotic protec-related with a massive release of IL-1, TNF-α, and γinterferon (γ-IF) (5) . Moreover, exposure to endotoxin tive and anti-inflammatory effects have been observed 1238 BALIBREA DEL CASTILLO ET AL. (36) . Thus, such effects could be useful in blocking or (5 ng/ml; FK506; Fujisawa; Osaka, Japan) was added where indicated. ameliorating innate immunity-related events that prevent early graft loss due to primary nonfunction and improv-Experimental Groups ing graft survival (27, 28) .
The main aim of our study was to investigate whether Islets from five different donors where assigned to four different experimental groups (control, treatment, the above mentioned effect of tacrolimus could be useful in protecting human islets cultured in the presence or stimulus, and stimulus + treatment). absence of several proinflammatory mediators. In order Measurements to evaluate islet damage we measured different apoptotic markers and insulin concentration. Also, TNF-α and IL-RPMI-1640 cultured samples of 300 IE were homogenized after sequential centrifugation (600 × g × 2; 5500 × 6 levels were assessed as indicators of the inflammatory response.
g × 2; 2400 × g; 10,000 × g) to obtain microsomal and cytosolic material.
MATERIALS AND METHODS
Apoptosis Assessment. For nucleosome, Bcl-2, and Islet Isolation caspase-3, -8, and -9 levels, programmed cell death was Human islets were obtained from cadaveric donors in evaluated by determination of five different related our institution. Specific consent was obtained from the markers. Nucleosome content (IU/islet), Bcl-2-related donors' relatives and the local Police Court according protein levels (IU/islet), and caspase-3, -8, and -9 conto Spanish/European Union Regulation. Pancreatic islets centration (nmol/islet × g24 h) were measured by were isolated following standard islet transplantation ELISA/spectrophotometry commercial kits (Calbiochem, protocols described elsewhere but with research pro-La Jolla, CA, USA and Canada). posal only due to Spanish National Transplantation Or-Insulin Secretion. For each experimental group insuganization restrictions. After pancreata were obtained, lin concentration (ng/islet) was measured in the culture they were preserved in a Wisconsin University solution medium after 24 h using a commercial kit for radioimat 2°C. After careful dissection and extirpation of surmunoassay (Demeditec, Kiel, Germany). rounding connective tissue, the main pancreatic duct Proinflammatory Mediators. TNF-α and IL-6 24-h was cannulated using a 14 Fr Abbocath catheter. Collamedia concentrations (pg/islet) were determined by spegenase P solution (2 mg/ ml; 1213865; Roche Diagnoscific ELISA kits (Biosource, Nivelles, Belgium). tics, Laval, Canada) was perfused until complete capsule distension. Enzymatic digestion process took place at Statistical Analysis 37°C in a closed chamber (Bio-Rep, Miami, FL, USA).
Statistical analysis was carried out with Statgraphics Digestion was stopped adding 4°C Hank's solution Plus 5.1 package (Statpoint Inc., USA) for Microsoft (PAA Laboratories GmbH, Linz, Austria) four consecu-Windows NT. Mean comparison was performed using tive times when an approximate 200,000 islet-equivalent factorial analysis of variance (ANOVA) with post hoc yield was reached. Because isolated islets were visible Scheffé's test. Results are expressed as mean ± SEM. A after 20 mg/ml dithizone (Sigma-Aldrich, St. Louis, 95% confidence level was considered significant. MO, USA) red staining, viability was evaluated every 2 min by direct microscopic vision. Ficoll (Sigma Chemi-RESULTS cal Co., St. Louis, MO, USA) gradient was applied in a Nucleosome Apoptosis COBE (Denver, CO, USA) cell processor. Remnant is-IL-1 + γ-IF addition was associated with a significant lets were collected under direct vision and packed in 300 increase of nucleosome content. In those islets treated islet-equivalent (IE) groups.
with tacrolimus, nucleosome concentration was signifi-Pancreatic Islet Culture and Cytokine Addition cantly lower than in cytokine-exposed islets, being comparable to controls. In the same way, endotoxin stimula-Twenty-four hour islet culture was performed using RPMI-1640 (PAA Laboratories GmbH, Linz, Austria) at tion produced a significant increase in nucleosome content. In this case tacrolimus also diminished nucleo-37°C, 95% O 2 /5% CO 2 . Glucose 11.11 mM solution and bovine serum albumin (0.1%; Sigma Chemical Co.) sup-some content to baseline ( Fig. 1 ). plements were also included. Pancreatic islet cytokine Bcl-2 Apoptosis exposure was achieved after adding to the medium 10 µg/ml Escherichia coli lipopplysaccharide (E5B55 LPS;
Bcl-2 expression was significantly lower after IL-1 + γ-IF stimulation. In the presence of tacrolimus Bcl-2 Sigma-Aldrich) or 50 IU/ml interleukin-1 (IL-1) (Boehringer Mannheim GmbH, Germany) and 1000 IU/ml γprotein levels were restored to basal values. When LPS was added, islets showed an important descent in Bcl-2 IF (Boehringer Mannheim GmbH). Low-dose tacrolimus values that were restored partially after tacrolimus treat-TNF and IL-6 Production ment (Fig. 2) .
Addition of IL-1 + γ-IF to cultured islets resulted in higher TNF-α values. Such increase was neutralized Caspases Apoptosis with low-dose tarcrolimus down to control-equivalent In both IL-1 + γ-IF and LPS groups, caspase-3 levels values. Moreover, LPS stimulation was also followed by increased markedly (Figs. 3 and 4 ). Tacrolimus addition upregulation of TNF-α release and tacrolimus treatment decreased caspase-3 values in cytokine-and LPS-stimureduced cytokine levels to baseline ( Fig. 6 ). Proinflamlated groups, becoming comparable to baseline levels in matory stimulation with IL-1 + γ-IF resulted in a signifi-IL-1 + γ-IF-exposed islets. Caspase-8 values after both cant increase of IL-6. In low-dose tacrolimus-treated iscytokine and endotoxin stimulation demonstrated a sharp lets IL-6 values were decreased, becoming comparable increase. Seemingly, tacrolimus addition diminished to those observed in controls in both experiments. caspase-8 levels in both experiments. However, this effect did not achieved values comparable to those ob-DISCUSSION served in nonstimulated islets. When caspase-9 levels were measured after IL-1 + γ-IF stimulation, a substan-Proinflammatory cytokine release and proapoptotic events are responsible of different pathophysiologic phe-tial increase was observed when compared to controls. Caspase-9 levels in stimulated islets also increased when nomena that lead to islet loss and primary nonfunction after transplantation (3, 31) . In order to reproduce in LPS was used. Tacrolimus addition diminished caspase-9 levels down to normal values in both experiments.
vitro a proinflammatory environment related to primary nonfunction of islet graft, cultured human pancreatic is-Insulin Concentration lets were challenged with cytokines and endotoxin and treated later by adding low-dose tacrolimus. After both LPS and IL-1 + γ-IF stimulation, 24-h insulin medium concentration decreased significantly. FK-Little is known about the FK-506-protective effect against primary rejection of transplanted islets. Unspeci-506-treated islets showed higher insulin concentration in comparison with the stimulus-only group in both experi-fic anti-inflammatory and antioxidant effects have been attributed to FK-506 while its in vitro and in vivo effect ments. Hormone levels after low-dose tacrolimus treatment were comparable to controls in tacrolimus + LPS on apoptotic phenomena remain not completely elucidated. Our results indicate that tacrolimus has a power-group (Fig. 5 ). In addition, control islets showed an acceptable 24-h insulin release, which can be considered ful protective effect on in vitro human islets when challenged by a proinflammatory environment ameliorating as an indirect function assessment. apoptosis and cytokine release and increasing insulin reported after high-dose (50-100 ng/ml) tacrolimus, suggesting a dose-response effect that was ameliorated content.
Despite the fact this is an in vitro study and results after promotion of antiapoptotic XIAP gene transduction (18) . must be interpreted carefully, islets were obtained from cadaveric donors following standard real-time isolation
As an explanation for tacrolimus effects on apoptosis, intrinsic characteristics of FK binding protein 38 (FKBP-procedure and the cytokines employed have been related as triggers in islet transplantation primary nonfunction 38) have been suggested. FKBP-38 + calmodulin complex varies both expression and function of antiapoptotic previously (3, 6) . LPS is a potent activator of innate immunity response via Toll-like receptor 4 activation, agent Bcl-2 (1, 10) . FKBP activation and linkage to Bcl-2 occurs due to tertiary structure of the later, which pre-among others (8) . Additionally, its presence within collagenase and liberase blends has been reported as a con-sents a "wide loop" between amino acids of its first and second α-helix. FKBP-Bcl-2 interaction ends when tributor to deleterious inflammatory reaction during isolation process (9, 41) . Cytokine concentration used as Bcl-2 is located near to mitocondrial membrane and exerts an antiapoptotic effect. A putative nuclear migration stimulus in our experiments was similar to that previously employed (11) .
of NF-κB has been proposed as an explanation (21, 23, 35) . Our results indicate that FK-506 exerts an antiapoptotic effect on mediator-stimulated human islets. Tacro-In our study, low-dose tacrolimus augmented insulin medium content after proinflammatory stimulation with-limus effects on apoptosis are highly variable and are tissue or even cell dependent (20). In spite of its proapo-out negative effects on hormone release. Our measurements include insulin accumulation in an 11 mM solu-ptotic effects on lymphocytes (16) , when unspecific proinflammatory stimulation is present, apoptosis blockade tion that may be considered glucose-stimulated insulin release. Nevertheless, comparison between insulin re-can occur. FK-506 does not affect normal apoptotic patterns observed in involution of normal tissues or physio-lease into high (16 mM) versus low (2.8 mM) media could be useful in order to identify possible glucose-logic atrophy in animal models (38) , and can stimulate human tissue regeneration (33) . In contrast to our re-stimulated insulin release variations due to tacrolimus addition. sults, downregulation of Bcl-2 and Bcl-XL concentrations in fresh isolated (nonstimulated) islets has been
There is little evidence about real long-term systemic and insular side effects of low-dose tacrolimus (31) . Ad-also been observed an inhibitory effect of tacrolimus on insulin secretion due to a hypothetic selective glucoki-verse side effects of FK-506 on glycemic metabolism are well known and could explain failure to achieve nase blockade (40) without decrease of insulin content, which is consistent with our findings. Conversely, previ-long-term insulin independence after islet transplantation under novel immunosuppressive protocols (4). The ous experiments have shown a decrease in transcription of the insulin gene in rats exposed to high-dose (0.1 mg/ present article does not include a dose-response study, but similar FK-506 concentrations used in the present kg; 50 ng/ml) tacrolimus. However, this phenomenon was only seen after 5 days of tacrolimus treatment (17). article have been tested in murine and pig models without short-term impairment of either baseline or after-These data suggest that although there are important side effects on insulin secretion after high-dose/long-term ta-stimulus insulin secretion. Unfortunately, these results are not maintained after long-term follow-up (19) . It has crolimus treatment, low-dose immunosuppression could be useful in preventing adverse primary nonfunction-sponse in the very first hours after islet transplantation is widely accepted (14, 15, 29) and its liberation during related events within the first hours after transplantation without impairment of islet insulin release. Nowadays, primary rejection of islet graft has different sources: host and islet-resident macrophages, β-cells, and hepatic en-promising results using nondiabetogenic FK-506 analogues such as FTY 720 have been reported (2) . dothelium (3) . Thus, TNF-α blockade is one of the most important targets to improve islet allograft tolerance. A protective effect was also observed by diminishing proinflammatory mediators after stimulation. Pancreatic Both monoclonal antibodies (infliximab) and soluble receptor analogues (etarnercept) have been used. Few re-islets are very sensitive to cytokines and many cytoprotective strategies have been proposed to improve graft ports about use of TNF-α blockade in human islet transplantation have been published since the Miami group survival. The role of TNF-α in acute inflammatory re-experience (12) . Low-dose tacrolimus effects on TNF-α have shown that immune cells proinflammatory cytokine release (IL-1, IL-6) after LPS stimulation dimin-release have not been thoroughly studied. Tacrolimus has shown a blockade effect on cytokine release in dif-ishes significantly after tacrolimus treatment (22, 25) but effects on stimulated pancreatic islets have not been ferent unspecific inflammatory models such as severe acute pancreatitis (30) or renal cortex cells stimulated carefully investigated. Role of IL-6 on pancreatic islets remains obscure. Although it has been accepted that this with LPS, IL-1, and TNF-α (42) . Also, a protective effect against immediate blood-mediated inflammatory re-cytokine had negative effects on islets (39), Choi and collaborators have observed protective effects by dimin-action has been found after tacrolimus administration specially after neural posttraumatic injury (37). ishing other proinflammatory mediators (7) . Our results indicate that FK-506 can ameliorate IL-6 after proin-Tacrolimus protective effects on immediate inflammatory response have also been studied in hepatic ische-flammatory stimulation similar to observed in primary rejection phenomena, helping to create a favorable islet mia-reperfusion models, by blocking oxidative stress and in situ liberation of IL-1 and TNF-α (13). Thus, environment. This article shows that tacrolimus protects islets from potential amelioration of inflammatory events within the liver can be another positive effect of tacrolimus immu-proapoptotic phenomena, insulin release impairment, and cytokine release observed after proinflammatory nosuppression in islet transplantation. Previous reports Tacrolimus effect on islet cytokine release after proinflammatory stimulation. Graphics show TNF-α and IL-6 levels (mean ± SEM) in the presence of IL-1 (50 IU/ml) + γ-IF (1000 IU/ ml) and LPS (10 mg/ml) and addition of tacrolimus where indicated. TNF-α levels were significantly higher when mediators were present. In tacrolimus-treated islets, TNF-α levels diminished not only in the presence of IL-1 + γ-IF but also in the LPS-stimulated group to baseline. A similar effect was observed when IL-6 levels were measured. When tacrolimus (5 ng/ml) was added to culture medium, IL-6 levels diminished down to comparable levels to controls. *p < 0.05 versus all others. berg, L.; Tchervenkov, J.; Paraskevas, S. Tumor necrosis factor-alpha production by human islets leads to postisola-
